Exarafenib (KIN-2787): Mechanism of Action

Exarafenib (KIN-2787) MOA：Targeting pan-RAF/MAPK Pathway for Melanoma

🎯 check Exarafenib (KIN-2787) product page

Exarafenib (KIN-2787) is a potent, selective pan-RAF inhibitor. It affects MAPK signaling by binding RAF, inhibiting pERK.

Primary Applications and Mechanism of Action

Jump to: